Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5085757
Max Phase: Preclinical
Molecular Formula: C37H40N4O2
Molecular Weight: 572.75
Molecule Type: Unknown
Associated Items:
ID: ALA5085757
Max Phase: Preclinical
Molecular Formula: C37H40N4O2
Molecular Weight: 572.75
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)(C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NCc1ccc(-c2ccccc2)cc1
Standard InChI: InChI=1S/C37H40N4O2/c1-37(2,3)41-36(43)34(23-30-25-39-32-17-11-10-16-31(30)32)40-35(42)33(22-26-12-6-4-7-13-26)38-24-27-18-20-29(21-19-27)28-14-8-5-9-15-28/h4-21,25,33-34,38-39H,22-24H2,1-3H3,(H,40,42)(H,41,43)/t33-,34-/m0/s1
Standard InChI Key: QNINBMOJXAPEAU-HEVIKAOCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 572.75 | Molecular Weight (Monoisotopic): 572.3151 | AlogP: 6.18 | #Rotatable Bonds: 11 |
Polar Surface Area: 86.02 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 4 |
#RO5 Violations: 2 | HBA (Lipinski): 6 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.80 | CX Basic pKa: 7.82 | CX LogP: 6.57 | CX LogD: 6.01 |
Aromatic Rings: 5 | Heavy Atoms: 43 | QED Weighted: 0.15 | Np Likeness Score: -0.42 |
1. Di Sarno V, Lauro G, Musella S, Ciaglia T, Vestuto V, Sala M, Scala MC, Smaldone G, Di Matteo F, Novi S, Tecce MF, Moltedo O, Bifulco G, Campiglia P, Gomez-Monterrey IM, Snoeck R, Andrei G, Ostacolo C, Bertamino A.. (2021) Identification of a dual acting SARS-CoV-2 proteases inhibitor through in silico design and step-by-step biological characterization., 226 [PMID:34571172] [10.1016/j.ejmech.2021.113863] |
Source(1):